Trial ID or NCT#



not recruiting iconNOT RECRUITING


Heparin is frequently used in central venous catheters (CVCs) in post-operative cardiac patients. It remains unclear if a heparin infusion, compared to a normal saline infusion, prevents thrombosis of CVCs after surgery. This study will answer the question: does a low-dose heparin infusion (10 units/kg/h) prevent thrombosis, compared to a normal saline infusion, in patients less than one year of age after cardiac surgery?

Official Title

Heparin and Catheter-related Thrombosis in Neonates and Infants Following Cardiac Surgery

Eligibility Criteria

Ages Eligible for Study: Younger than 1 Year
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No


Stephen J. Roth
David M. Axelrod, MD

Contact us to find out if this trial is right for you.


David Axelrod
(415) 607-2463